Enliven Therapeutics
ELVN
#5642
Rank
A$1.80 B
Marketcap
A$30.39
Share price
3.49%
Change (1 day)
-18.55%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.58 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is A$0.58 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2025)

Total debt by year

Year Total debt Change
2024-12-31N/A-100%
2023-12-31A$0.49 M3.59%
2022-12-31A$0.47 M116.42%
2021-12-31A$0.21 M60.61%
2020-12-31A$0.13 M